153 related articles for article (PubMed ID: 15486896)
1. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
[TBL] [Abstract][Full Text] [Related]
2. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis.
Thummarati P; Wijitburaphat S; Prasopthum A; Menakongka A; Sripa B; Tohtong R; Suthiphongchai T
World J Gastroenterol; 2012 Jan; 18(3):244-50. PubMed ID: 22294827
[TBL] [Abstract][Full Text] [Related]
3. Urokinase and its receptors in chronic kidney disease.
Zhang G; Eddy AA
Front Biosci; 2008 May; 13():5462-78. PubMed ID: 18508599
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
Mahmood N; Mihalcioiu C; Rabbani SA
Front Oncol; 2018; 8():24. PubMed ID: 29484286
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.
Wang S; Jiang L; Han Y; Chew SH; Ohara Y; Akatsuka S; Weng L; Kawaguchi K; Fukui T; Sekido Y; Yokoi K; Toyokuni S
Oncotarget; 2016 Oct; 7(43):69565-69578. PubMed ID: 27602956
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.
Alfano M; Sidenius N; Panzeri B; Blasi F; Poli G
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8862-7. PubMed ID: 12084931
[TBL] [Abstract][Full Text] [Related]
7. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.
Bin Hafeez B; Adhami VM; Asim M; Siddiqui IA; Bhat KM; Zhong W; Saleem M; Din M; Setaluri V; Mukhtar H
Clin Cancer Res; 2009 Jan; 15(2):452-9. PubMed ID: 19147749
[TBL] [Abstract][Full Text] [Related]
8. Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.
Memarzadeh S; Kozak KR; Chang L; Natarajan S; Shintaku P; Reddy ST; Farias-Eisner R
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10647-52. PubMed ID: 12130664
[TBL] [Abstract][Full Text] [Related]
9. uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues.
Meng S; Tripathy D; Shete S; Ashfaq R; Saboorian H; Haley B; Frenkel E; Euhus D; Leitch M; Osborne C; Clifford E; Perkins S; Beitsch P; Khan A; Morrison L; Herlyn D; Terstappen LW; Lane N; Wang J; Uhr J
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17361-5. PubMed ID: 17079488
[TBL] [Abstract][Full Text] [Related]
10. IL4 stimulated macrophages promote axon regeneration after peripheral nerve injury by secreting uPA to stimulate uPAR upregulated in injured axons.
Matsui Y; Kadoya K; Nagano Y; Endo T; Hara M; Matsumae G; Suzuki T; Yamamoto Y; Terkawi MA; Iwasaki N
Cell Mol Life Sci; 2022 May; 79(6):289. PubMed ID: 35536429
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the incidence, characteristics, and risk factors of complications during induction chemotherapy in children with high-risk neuroblastoma.
Du J; Yuan X
Eur J Pediatr; 2024 Jan; 183(1):185-202. PubMed ID: 37855927
[TBL] [Abstract][Full Text] [Related]
12. Systematic computational identification of prognostic cytogenetic markers in neuroblastoma.
Qin C; He X; Zhao Y; Tong CY; Zhu KY; Sun Y; Cheng C
BMC Med Genomics; 2019 Dec; 12(1):192. PubMed ID: 31831008
[TBL] [Abstract][Full Text] [Related]
13. Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic review.
Camedda R; Frantellizzi V; Danieli R; De Vincentis G; Filippi L
Expert Rev Anticancer Ther; 2024; 24(3-4):137-145. PubMed ID: 38451196
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow relapse in stage 4 neuroblastoma of children in Shanghai.
Li H; Zhao J; Yang J; Tang J; Zhang T; Jiang H; Shao J
Am J Cancer Res; 2024; 14(1):145-154. PubMed ID: 38323287
[TBL] [Abstract][Full Text] [Related]
15. Advances in the Surgical Treatment of Neuroblastoma.
Luo YB; Cui XC; Yang L; Zhang D; Wang JX
Chin Med J (Engl); 2018 Oct; 131(19):2332-2337. PubMed ID: 30246719
[TBL] [Abstract][Full Text] [Related]
16. Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.
Hao W; Friedman A
PLoS One; 2016; 11(4):e0153508. PubMed ID: 27078836
[TBL] [Abstract][Full Text] [Related]
17. Serum cholesterol level as a predictive biomarker for prognosis of Neuroblastoma.
Min J; Wu Y; Huang S; Li Y; Lv X; Tang R; Zhao H; Wang J
BMC Pediatr; 2024 Mar; 24(1):205. PubMed ID: 38519890
[TBL] [Abstract][Full Text] [Related]
18. Persistence of Racial and Ethnic Disparities in Risk and Survival for Patients with Neuroblastoma over Two Decades.
Chennakesavalu M; Pudela C; Applebaum MA; Lee SM; Che Y; Naranjo A; Park JR; Volchenboum SL; Henderson TO; Cohn SL; Desai AV
EJC Paediatr Oncol; 2023 Dec; 2():. PubMed ID: 38213818
[TBL] [Abstract][Full Text] [Related]
19. A finite mixture survival model to characterize risk groups of neuroblastoma.
Hunsberger S; Albert PS; London WB
Stat Med; 2009 Apr; 28(8):1301-14. PubMed ID: 19184977
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcomes of 1041 pediatric patients with neuroblastoma who received multidisciplinary care in China.
Su Y; Qin H; Chen C; Wang S; Zhang S; Zhang D; Jin M; Peng Y; He L; Wang X; Qian S; Qin M; Ge M; Zhang F; Zeng Q; Wang H; Ma X; Ni X
Pediatr Investig; 2020 Sep; 4(3):157-167. PubMed ID: 33150309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
